These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34174496)

  • 41. Discontinuation of Oxytocin in the Second Stage of Labor and its Association with Postpartum Hemorrhage.
    MacGregor C; Plunkett B; Adams M; Silver R
    Am J Perinatol; 2024 Jun; 41(8):1050-1054. PubMed ID: 35240702
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective study of intramuscular ergometrine compared with intramuscular oxytocin for prevention of postpartum hemorrhage.
    Saito K; Haruki A; Ishikawa H; Takahashi T; Nagase H; Koyama M; Endo M; Hirahara F
    J Obstet Gynaecol Res; 2007 Jun; 33(3):254-8. PubMed ID: 17578351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of carbetocin and oxytocin for the prevention of postpartum hemorrhage following vaginal delivery:a double-blind randomized trial.
    Boucher M; Nimrod CA; Tawagi GF; Meeker TA; Rennicks White RE; Varin J
    J Obstet Gynaecol Can; 2004 May; 26(5):481-8. PubMed ID: 15151735
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Five unit bolus oxytocin at cesarean delivery in women at risk of atony: a randomized, double-blind, controlled trial.
    King KJ; Douglas MJ; Unger W; Wong A; King RA
    Anesth Analg; 2010 Dec; 111(6):1460-6. PubMed ID: 20889945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intramuscular oxytocin administration before vs. after placental delivery for the prevention of postpartum hemorrhage: A randomized controlled prospective trial.
    Yildirim D; Ozyurek SE
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():47-51. PubMed ID: 29533864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Weight-based versus fixed dose oxytocin infusion for preventing uterine atony during cesarean section in laboring patients: A randomized trial.
    Tyagi A; Bodh P; Mohta M; Gupta B
    Int J Gynaecol Obstet; 2024 Mar; 164(3):985-991. PubMed ID: 37715535
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and financial evaluation of carbetocin as postpartum haemorrhage prophylaxis at caesarean section: A retrospective cohort study.
    Wohling J; Edge N; Pena-Leal D; Wang R; Mol BW; Dekker G
    Aust N Z J Obstet Gynaecol; 2019 Aug; 59(4):501-507. PubMed ID: 30411314
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adjunctive rectal misoprostol versus oxytocin infusion for prevention of postpartum hemorrhage in women at risk: a randomized controlled trial.
    Badejoko OO; Ijarotimi AO; Awowole IO; Loto OM; Badejoko BO; Olaiya DS; Fatusi AO; Kuti O; Orji EO; Ogunniyi SO
    J Obstet Gynaecol Res; 2012 Nov; 38(11):1294-301. PubMed ID: 22612662
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparison of carbetocin and oxytocin effectiveness for prevention of postpartum hemorrhage after caesarean delivery].
    Brzozowska M; Lisiecki D; Kowalska-Koprek U; Karowicz-Bilińska A
    Ginekol Pol; 2015 Feb; 86(2):107-12. PubMed ID: 25807834
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Economic evaluation of carbetocin as prophylaxis for postpartum hemorrhage in the Philippines.
    Briones JR; Talungchit P; Thavorncharoensap M; Chaikledkaew U
    BMC Health Serv Res; 2020 Oct; 20(1):975. PubMed ID: 33106169
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dose and duration of oxytocin to prevent postpartum hemorrhage: a review.
    Roach MK; Abramovici A; Tita AT
    Am J Perinatol; 2013 Aug; 30(7):523-8. PubMed ID: 23208766
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of carbetocin and oxytocin infusions in reducing the requirement for additional uterotonics or procedures in women at increased risk of postpartum haemorrhage after Caesarean section.
    Tse KY; Yu FNY; Leung KY
    Hong Kong Med J; 2020 Oct; 26(5):382-389. PubMed ID: 33028723
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Postpartum hemorrhage: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF): in collaboration with the French Society of Anesthesiology and Intensive Care (SFAR).
    Sentilhes L; Vayssière C; Deneux-Tharaux C; Aya AG; Bayoumeu F; Bonnet MP; Djoudi R; Dolley P; Dreyfus M; Ducroux-Schouwey C; Dupont C; François A; Gallot D; Haumonté JB; Huissoud C; Kayem G; Keita H; Langer B; Mignon A; Morel O; Parant O; Pelage JP; Phan E; Rossignol M; Tessier V; Mercier FJ; Goffinet F
    Eur J Obstet Gynecol Reprod Biol; 2016 Mar; 198():12-21. PubMed ID: 26773243
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery.
    Elbohoty AE; Mohammed WE; Sweed M; Bahaa Eldin AM; Nabhan A; Abd-El-Maeboud KH
    Int J Gynaecol Obstet; 2016 Sep; 134(3):324-8. PubMed ID: 27350226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of initiating intravenous oxytocin infusion before uterine incision on the blood loss during elective cesarean section: a randomized clinical trial.
    Abdelaleem AA; Abbas AM; Thabet AL; Badran E; El-Nashar IH
    J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3723-3728. PubMed ID: 29712515
    [No Abstract]   [Full Text] [Related]  

  • 56. Efficacy of oxytocin versus carbetocin in prevention of postpartum hemorrhage after cesarean section under general anesthesia: a prospective randomized clinical trial.
    Taheripanah R; Shoman A; Karimzadeh MA; Zamaniyan M; Malih N
    J Matern Fetal Neonatal Med; 2018 Nov; 31(21):2807-2812. PubMed ID: 28707488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intramuscular versus intravenous oxytocin for the third stage of labor after vaginal delivery to prevent postpartum hemorrhage: a meta-analysis of randomized controlled trials.
    Zhou YH; Xie Y; Luo YZ; Liu XW; Zhou J; Liu Q
    Eur J Obstet Gynecol Reprod Biol; 2020 Jul; 250():265-271. PubMed ID: 32439242
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evaluation of carbetocin (pabal) efficacy in the prevention of the postpartum hemorrhage in women after cesarean section--preliminary report].
    Kalinka J; Lipińska M; Sosnowski D; Wiliński W; Skoczylas M; Serafin M; Prośniewska M; Krajewski P; Laudański T
    Ginekol Pol; 2009 Jul; 80(7):512-7. PubMed ID: 19697815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Misoprostol: off-label use in the treatment of post-partum hemorrhage].
    Garrigue A; Pierre F
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):179-89. PubMed ID: 24457021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence and risk factors for postpartum hemorrhage in Uganda.
    Ononge S; Mirembe F; Wandabwa J; Campbell OM
    Reprod Health; 2016 Apr; 13():38. PubMed ID: 27080710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.